Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Retail volume sales of analgesics rebounded in 2023, following a two-year period of decline. While the COVID-19 pandemic boosted demand for acetaminophen (paracetamol), which was the only analgesic recommended by the government to alleviate the…
While analgesics performed well during the pandemic, they has returned to more moderate growth now that the threat has subsided. In 2023, analgesics is expected to register moderate current value growth, though constant value sales are expected to…
Analgesics is set to maintain steady current value growth in Brazil in 2023, and will remain the largest category within OTC, with a 40% share of value sales. The consumption of analgesics is mainly related to general pain, fever, and the relief of…
In 2023, acetaminophen continues to lead sales of analgesics in Chile, whilst also experiencing the highest growth rate in the category. This growth has remained steady since the onset of the pandemic, where acetaminophen became the preferred choice…
After the spike in demand for systemic analgesics in the period, 2020 to 2021, driven by COVID-19 and then by the need to relieve reactions to vaccination, in 2022 demand tended to stabilise. However, adult acetaminophen and combination analgesics…
Rising inflation has caused consumers to be increasingly stressed in 2023, with rising price points and ongoing economic uncertainty negatively impacting lives. This ongoing uncertainty has led to an increase in physical discomforts; often in the…
Analgesics has not seen a positive performance in 2023 as the height of the pandemic has passed. During the pandemic’s peak, consumers were buying up analgesics at a rapid pace to treat fevers, aches and other symptoms associated with acute…
Pharmacies continue to have significant influence over the value sales of analgesics in Ecuador. For instance, in lower income neighbourhoods, pharmacies are generally stocked with generics, whereas in wealthier neighbourhoods, mainly branded…
Analgesics is set to see a decline in sales in 2023 as consumers have migrated away from aspirin in an uncertain economic environment and sought to prioritise household essentials, while turning to other categories to treat basic ailments such as…
In late 2022 and into early 2023, a convergence of COVID-19, seasonal flu, and heightened influenza cases created what the media termed a "tripledemic," impacting Mexico, the US, and Central American nations. While Mexico did not experience the same…
Analgesics benefitted from the era of COVID-19, as consumers sought out pain relief such as acetaminophen and ibuprofen, both of which saw extensive coverage in the media as low-cost products that could treat symptoms of the virus quickly and…
Though current value sales are expected to rise, constant value sales are expected to fall, as continuing rising operating costs cut into profitability. In 2023, with concerns about COVID-19 abating, demand for analgesics reduces to more normal…
The briefing introduces the Cities Households Necessities Spending Index. The index ranks 1,075 cities by household expenditure on non-discretionary items, namely food, housing, and clothing and footwear. This analysis focuses on 160 major cities.…
During 2023, Argentina was plunged into an economic crisis, with the rate of inflation soaring to more than 100%, one of the highest in the world. With the country already struggling to comply with the conditions of a loan package from the…
Bolivia has managed to protect itself to a large extent from inflation by continuing to have a fixed exchange rate against the dollar. However, there has been challenges for the economy in 2023, with sharp falls in foreign currency reserves and this…
Consumer health in Brazil is expected to close 2023 with double-digit growth in current value terms for the third consecutive year. While in previous years, the COVID-19 pandemic boosted demand for cough, cold and allergy (hay fever) remedies, as…
Consumer health in Chile experienced a notable slowdown in value growth in 2022 compared to the previous year's performance. In 2021, the pandemic-induced liquidity in the local market and the shift towards preventive habits among consumers drove…
In 2023, Colombians returned to their familiar routines, with increasing social activity and hectic lifestyles leading to an increase in cases of cold and benefiting most OTC categories. However, the opposite trend is being observed in vitamins and…
In 2023, increased socialising and the return to post-pandemic habits support the growth of several OTC categories. However, high inflation and a fluctuating exchange rate continue to create uncertainty. Inflation in Costa Rica was 8.27% in 2022, the…
Despite persistent inflationary pressures in the country and wages that have not yet caught up with market conditions, consumer health recorded growth in 2023. Growth was supported by solid categories, including cough, cold and allergy (hay fever)…